- Home
- PROK vs FRA Comparison
PROK vs FRA Comparison
Compare PROK & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FRA
- Stock Information
- Founded
- PROK 2015
- FRA 2003
- Country
- PROK United States
- FRA United States
- Employees
- PROK N/A
- FRA N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FRA Investment Bankers/Brokers/Service
- Sector
- PROK Health Care
- FRA Finance
- Exchange
- PROK Nasdaq
- FRA Nasdaq
- Market Cap
- PROK 417.1M
- FRA 437.8M
- IPO Year
- PROK N/A
- FRA N/A
- Fundamental
- Price
- PROK $2.78
- FRA $12.35
- Analyst Decision
- PROK Strong Buy
- FRA
- Analyst Count
- PROK 4
- FRA 0
- Target Price
- PROK $6.25
- FRA N/A
- AVG Volume (30 Days)
- PROK 1.5M
- FRA 165.4K
- Earning Date
- PROK 11-10-2025
- FRA 01-01-0001
- Dividend Yield
- PROK N/A
- FRA 11.06%
- EPS Growth
- PROK N/A
- FRA N/A
- EPS
- PROK N/A
- FRA N/A
- Revenue
- PROK $744,000.00
- FRA N/A
- Revenue This Year
- PROK $471.74
- FRA N/A
- Revenue Next Year
- PROK N/A
- FRA N/A
- P/E Ratio
- PROK N/A
- FRA N/A
- Revenue Growth
- PROK N/A
- FRA N/A
- 52 Week Low
- PROK $0.46
- FRA $11.33
- 52 Week High
- PROK $7.13
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- PROK 45.61
- FRA 31.09
- Support Level
- PROK $2.56
- FRA $12.32
- Resistance Level
- PROK $2.94
- FRA $12.52
- Average True Range (ATR)
- PROK 0.23
- FRA 0.12
- MACD
- PROK -0.05
- FRA -0.00
- Stochastic Oscillator
- PROK 25.41
- FRA 4.49
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.